Please use this identifier to cite or link to this item:
|Title:||Defending male fertility||Authors:||Rozen, S.||Issue Date:||20-Jul-2011||Citation:||Rozen, S. (2011-07-20). Defending male fertility. Science Translational Medicine 3 (92) : -. ScholarBank@NUS Repository. https://doi.org/10.1126/scitranslmed.3002743||Abstract:||An estimated 10 to 15% of couples suffer from infertility, and many treatment decisions rely on trial and error. In this issue of Science Translational Medicine, Tollner and colleagues provide strong evidence from a human genetics study that a common variant in the beta defensin 126 gene, the "del" variant, can reduce male fertility substantially. In addition, they show a plausible mechanism for reduced fertility: Sperm from del/del homozygotes lack an important component of their glycoprotein coat and have difficulty penetrating a surrogate for cervical mucus. If replicated in future studies, these findings promise to guide choices about the timing and type of assisted reproduction interventions - and further hint at the possibility of treating sperm from del/del homozygotes to promote fertility.||Source Title:||Science Translational Medicine||URI:||http://scholarbank.nus.edu.sg/handle/10635/110696||ISSN:||19466234||DOI:||10.1126/scitranslmed.3002743|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.